Generali Asset Management SPA SGR reduced its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 24.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,169 shares of the company's stock after selling 5,914 shares during the quarter. Generali Asset Management SPA SGR's holdings in Docusign were worth $1,415,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in DOCU. GAMMA Investing LLC grew its holdings in shares of Docusign by 338.2% during the first quarter. GAMMA Investing LLC now owns 3,519 shares of the company's stock valued at $286,000 after buying an additional 2,716 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Docusign by 26.2% during the first quarter. Fifth Third Bancorp now owns 1,391 shares of the company's stock valued at $113,000 after buying an additional 289 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Docusign by 528.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 108,232 shares of the company's stock valued at $8,810,000 after buying an additional 91,017 shares during the last quarter. Ritholtz Wealth Management grew its holdings in shares of Docusign by 58.5% during the first quarter. Ritholtz Wealth Management now owns 3,926 shares of the company's stock valued at $320,000 after buying an additional 1,449 shares during the last quarter. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Docusign by 6.6% during the first quarter. Janney Montgomery Scott LLC now owns 41,359 shares of the company's stock valued at $3,367,000 after buying an additional 2,554 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Docusign news, insider James P. Shaughnessy sold 7,500 shares of Docusign stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total value of $533,925.00. Following the sale, the insider owned 55,442 shares of the company's stock, valued at approximately $3,946,915.98. The trade was a 11.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Allan C. Thygesen sold 40,000 shares of Docusign stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $69.69, for a total transaction of $2,787,600.00. Following the completion of the sale, the chief executive officer directly owned 136,246 shares in the company, valued at approximately $9,494,983.74. This represents a 22.70% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 102,533 shares of company stock valued at $7,709,933. Company insiders own 1.01% of the company's stock.
Docusign Stock Performance
Shares of DOCU stock opened at $67.93 on Friday. The firm has a market cap of $13.66 billion, a price-to-earnings ratio of 51.08, a P/E/G ratio of 3.34 and a beta of 1.02. Docusign Inc. has a 52 week low of $66.35 and a 52 week high of $107.86. The firm's 50-day simple moving average is $75.02 and its two-hundred day simple moving average is $77.97.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company's revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Analysts forecast that Docusign Inc. will post 1.17 earnings per share for the current year.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on DOCU. Wall Street Zen upgraded shares of Docusign from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. Piper Sandler raised their price target on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Morgan Stanley raised their price target on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research report on Monday, September 8th. JMP Securities reissued a "market outperform" rating and set a $124.00 price target on shares of Docusign in a research report on Friday, October 3rd. Finally, Wells Fargo & Company raised their price target on shares of Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research report on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Docusign has a consensus rating of "Hold" and a consensus target price of $94.14.
Read Our Latest Stock Analysis on Docusign
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.